Laughing gas relieves symptoms in people with treatment-resistant depression
Researchers at the School of Medicine and the University of Chicago have found that a single, one-hour treatment that involves breathing in laughing gas can significantly improve symptoms in people with treatment-resistant depression.
Global travelers pick up numerous genes that promote microbial resistance
New School of Medicine research shows that international travelers often return home with new bacterial strains jostling for position within the gut microbiome. Such travel is contributing to the rapid global increase and spread of antimicrobial resistance.
Board grants faculty appointments, promotions, tenure
At the Washington University in St. Louis Board of Trustees meeting May 7, numerous faculty members were appointed or promoted with tenure or granted tenure, with most effective July 1.
Newly approved drug effective against lung cancer caused by genetic mutation
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The study is led by scientists at the School of Medicine and other institutions.
Studies reveal skull as unexpected source of brain immunity
Researchers at Washington University School of Medicine have discovered that the immune cells stationed in the protective tissue known as the meninges come primarily from the skull. The finding opens up the possibility of developing therapies to target such cells as a way to prevent or treat brain conditions.
New method predicts chemotherapy effectiveness after one treatment
An interdisciplinary team at Washington University finds that combining certain data after a patient’s first treatment can predict how a breast cancer tumor is responding to chemotherapy.
Tiny implant cures diabetes in mice without triggering immune response
Researchers at Washington University School of Medicine and Cornell University have implanted insulin-secreting cells into diabetic mice to normalize their blood sugar.
Synthetic data mimics real health-care data without patient-privacy concerns
Washington University investigators now have access to a new research tool that allows them to conduct clinical studies using synthetic patient data. Synthetic data produced by the new tool, called MDClone, accurately mimics real patient data without the privacy concerns.
Olin research: Incentivize domestic drug production to combat medicine shortages
Olin Business School’s Tony Sardella, along with Paolo De Bona, PMBA ’20, will join the Brookings Institution for a virtual public forum on June 11 to discuss their research on the shortage of critical pharmaceutical drugs in U.S.
Brown School works with Webster Groves to improve housing equity
Molly Metzger, senior lecturer at the Brown School, and students in her policy course have partnered with Webster Groves city council members and St. Louis’ Green City Coalition on a series of projects connected to the planning of community land trusts.
View More Stories